Skip to main
JAN

JAN Stock Forecast & Price Target

JAN Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 17%
Buy 75%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

Janus Living is in a strong position to capitalize on the current market opportunity in the senior housing sector as a pure-play healthcare REIT focused on RIDEA structures. With a recent investment activity of over $1.1 billion and a target to complete another $500 million by year-end, the company's focus on external growth through acquisitions and its strong management team are key factors that contribute to a positive outlook. Additionally, the company's solid balance sheet and liquidity provide ample runway for future investments, with projected strong organic growth and successful deployment of capital.

Bears say

Janus Living is rapidly increasing its senior housing portfolio through aggressive capital deployment, leading to better organic growth and prompting an increase in estimates. Additionally, the company's strong financial position and industry relationships are expected to drive healthy external growth. However, there are concerns surrounding the company's limited equity float and the potentially volatile nature of its cash NREFs, as well as the external management structure and potential conflicts it may create. There are also concerns about the company's reliance on equity issuances for funding, which could lead to dilution for current shareholders.

JAN has been analyzed by 12 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 75% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Janus Living Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Janus Living Inc (JAN) Forecast

Analysts have given JAN a Buy based on their latest research and market trends.

According to 12 analysts, JAN has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $32.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $32.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Janus Living Inc (JAN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.